Evidence map›Paper›PMID 33328142›Full record

ArticleVaccine2021

Evaluation of the safety profile of the vaccine candidate Brucella melitensis 16MΔvjbR strain in goats.

M Raquel Castaño-Zubieta, Carlos A Rossetti, Daniel G García-González, Estefanía Maurizio, Martha E Hensel, Allison C Rice-Ficht, Thomas A Ficht, Ángela M Arenas-Gamboa

Open access · greenAbstract read
In one paragraph

Article in Vaccine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

M Raquel Castaño-ZubietaInstituto de Patobiología, CICVyA-INTA (Instituto Nacional de Tecnología Agropecuaria), Nicolas Repetto y de Los Reseros s/n (B1686), Hurlingham, Bs. As., Argentina.
Carlos A RossettiInstituto de Patobiología, CICVyA-INTA (Instituto Nacional de Tecnología Agropecuaria), Nicolas Repetto y de Los Reseros s/n (B1686), Hurlingham, Bs. As., Argentina.
Daniel G García-GonzálezDepartment of Veterinary Pathobiology, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, 4467 TAMU, College Station, TX 77843, USA.
Estefanía MaurizioInstituto de Patobiología, CICVyA-INTA (Instituto Nacional de Tecnología Agropecuaria), Nicolas Repetto y de Los Reseros s/n (B1686), Hurlingham, Bs. As., Argentina; CONICET. Godoy Cruz 2290 (C1425) CABA, Argentina.
Martha E HenselDepartment of Veterinary Pathobiology, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, 4467 TAMU, College Station, TX 77843, USA.
Allison C Rice-FichtDepartment of Molecular and Cellular Medicine, College of Medicine, Texas A&M University, College Station, TX 77843, USA.
Thomas A FichtDepartment of Veterinary Pathobiology, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, 4467 TAMU, College Station, TX 77843, USA.
Ángela M Arenas-GamboaDepartment of Veterinary Pathobiology, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, 4467 TAMU, College Station, TX 77843, USA. Electronic address: aarenas@cvm.tamu.edu.
Texas A&M University · USNational Agricultural Technology Institute · ARConsejo Nacional de Investigaciones Científicas y Técnicas · AR

Funding

Comparative Biomedical Research Training for VeterinariansT32OD011083 · OD · TEXAS A&M AGRILIFE RESEARCH · PI ALBERT MULENGA · 2012 to 2026
$4.8M
Use of the goat model to test human Brucella vaccines in ArgentinaK01TW009981 · FIC · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI ARENAS, ANGELA M · 2014 to 2018
$670k
FIC NIH HHS K01 TW009981NIH HHS T32 OD011083
6 · The paper itself

Abstract

Small ruminant brucellosis is caused by the Gram negative cocci-bacillus Brucella (B.) melitensis, the most virulent Brucella species for humans. In goats and sheep, middle to late-term gestation abortion, stillbirths and the delivery of weak infected offspring are the characteristic clinical signs of the disease. Vaccination with the currently available Rev. 1 vaccine is the best option to prevent and control the disease, although it is far from ideal. In this study, we investigate the safety of the B. melitensis 16MΔvjbR strain during a 15-month period beginning at vaccination of young goats, impregnation, delivery and lactation. Forty, 4 to 6 months old, healthy female crossbreed goats were randomly divided into four groups (n = 10) and immunized subcutaneously with a single vaccine dose containing 1x10

Indexed as

Brucella melitensisBrucella VaccineBrucellosisSheep DiseasesAnimalsFemaleGoatsHumansPregnancySheepBrucella VaccineBrucellaBrucellosisGoatsMicroencapsulationVaccine

Identifiers

PMID33328142
PMCPMC8730362
OpenAlexW3112387062

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.